Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain, J. Biol. Chem, pp.258-2065, 1983. ,
The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes, J. Thromb. Haemost, vol.9, pp.679-688, 2011. ,
Congenital von Willebrand disease type3: clinical manifestations, pathophysiology and molecular biology, Best Pract. Res. Clin. Haematol, vol.14, pp.365-379, 2001. ,
DOI : 10.1053/beha.2001.0139
EJCs at the heart of translational control, Cell, vol.133, pp.213-216, 2008. ,
Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing, Haemophilia, vol.13, pp.645-648, 2007. ,
Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies, J. Thromb. Haemost, vol.8, pp.2736-2742, 2010. ,
Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay, Haematologica, vol.95, pp.172-174, 2010. ,
Enzyme immunoassay for factor VIII-related antigen, Clin. Chem, vol.28, pp.1356-1358, 1982. ,
Molecular characterization of Iranian patients with type 3 von Willebrand disease, Haemophilia, vol.15, pp.1058-1064, 2009. ,
Letter: a method for assaying von Willebrand factor (ristocetin cofactor), Thromb. Diath. Haemorrh, pp.34-306, 1975. ,
A novel method for quantitation of human von Willebrand factor messenger RNA, Thromb. Res, vol.106, pp.237-241, 2002. ,
Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique, Clin. Chem, pp.50-2271, 2004. ,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)) method, Methods, vol.25, pp.402-408, 2001. ,
Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients, Blood Cells Mol. Dis, pp.30-264, 2003. ,
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function, Genes Dev, vol.21, pp.1833-1856, 2007. ,
Killing the messenger: new insights into nonsense-mediated mRNA decay, J. Clin. Invest, vol.109, pp.3-6, 2002. ,
Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis, Proc. Natl. Acad. Sci. U. S. A, pp.88-3857, 1991. ,
A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing, Br. J. Haematol, pp.95-184, 1996. ,
Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA, Thromb. Haemost, pp.68-448, 1992. ,
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele, Br. J. Haematol, vol.80, pp.358-363, 1992. ,
A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay, Neuromuscul. Disord, vol.18, pp.886-889, 2008. ,
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics, Nat. Rev. Mol. Cell Biol, vol.5, pp.89-99, 2004. ,